Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)

17.26
Delayed Data
As of May 25
 -0.31 / -1.76%
Today’s Change
12.89
Today|||52-Week Range
19.94
+15.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues65.1M86.8M94.2M69.2M
 
 
 
 
 
Cost of Goods Sold1.6M4.3M7.3M817.0K
 
 
 
 
 
Depreciation And Amortization2.3M3.7M5.3M5.3M
 
 
 
 
 
 
Operating ExpensesGross Income61.2M78.8M81.6M63.1M
 
 
 
 
 
General Expenses95.1M98.8M98.1M96.0M
 
 
 
 
 
Research And Development37.3M37.1M40.1M36.5M
 
 
 
 
 
Total Operating Expenses99.1M106.8M110.7M102.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-34.0M-20.0M-16.5M-32.9M
 
 
 
 
 
Extraordinary Credit5.3M628.0K39.2M1.3M
 
 
 
 
 
Extraordinary Charge-7.0M-4.4M-2.1M-2.9M
 
 
 
 
 
Interest Expense On Debt9.0M9.1M9.2M9.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-44.2M-32.3M12.1M-43.1M
 
 
 
 
 
Net Income-44.2M-32.3M12.1M-43.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS148.8M149.5M149.9M151.0M
 
 
 
 
 
Shares To Calculate EPS Diluted148.8M149.5M149.9M151.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.30-$0.22$0.08-$0.29
 
 
 
 
 
EPS Diluted-$0.30-$0.22$0.08-$0.29